Real Solutions to Real Problems
™ invests its own funds to identify and solve technological gaps with clever, elegant and actionable advancements across five platforms.
We invest where three vectors of change are moving to coalesce into a perfect storm. Patent-first. Pre-revenue. Unavoidable.
BOTOX performance without BOTOX.
Unleashing Natural Biopolymer Performance.
Deep dive →Feeding the planet with less land and less water.
Harnessing Microbial Derived Secondary Metabolites.
Black hole on a chip.
Arriving at Topological QuBits for the Win.
Negative Poisson ratios in auxetics.
Tuning the Nonlinearity of Chiral Metamaterials.
Novel tech to repeal antimicrobial resistance.
Solving ESKAPE Pathogens One Letter at a Time.
« At ™ we believe that the SaaS-like investment playbook has created a system where traction is often mistaken for innovation. The ™ model: value creation around intellectual property. By focusing on global patents and trade-secrets as our core assets, we secure very valuable and defensible IP positions for our exit partners. »
— François Lamoureux, CEO
Own them before the market recognizes them.
Global patents and trade-secrets as the core asset.
Defensible IP positions for our exit partners.
Beauty: a $600B industry looking for a solution. We are the solution.
conducts cold, hard assessments of high-margin, large addressable markets — and invests where change converges.
The creams don't perform.
The proof is that people are turning to botox.
Microplastics & petrochemicals.
Microplastics are everywhere.
PFAS forever-chemical ban.
Microplastics are also being banned.
« I pay a lot for products that don't deliver on promises. »
Known for decades. Fully biodegradable. Better performance. Replaces microplastics. Displaces petrochemicals.
Chitosan is non-soluble and hard to use.
Scientific studies in SCOPUS exalt the extraordinary properties of chitosan — but with no solution to overcoming the non-solubility problem.
We solved the problem.
1 second — not 56 days. No Photoshop. No tricks. Taken on iPhone 15 Max. Paris, 2025-05-15.
Same test. Same lab. Laser-measured. CXC-SKIN wins.
Génifique, Lancôme, Essential Energy and Shiseido trademarks are owned by their respective owners. CXC is in no way affiliated with L'Oréal, Lancôme or Shiseido.
Reuters · 24 Mar 2026Breaking news: CXC announces allowance of its proprietary chitosan suspension technology patent in Canada and Australia.
Read release →European Business ReviewFrançois Lamoureux on operating with an IP Pharma mindset — and why few founders will choose it.
Read article →VentureBeatRethinking what innovation looks like when ownership of the solution matters more than the sale.
Read article →European Business Review« Playtime » has been the focus, not performance. We told the truth.
Read article →USA TodayHow overreliance on p-values is stifling innovation.
Read article →The IndependentUnearthing hidden potential — François Lamoureux on creativity as both gift and obligation.
Read article →Rolling Stone UK · 24 Jan 2025François Lamoureux on success, starting for the right and wrong reasons, and living off cereal.
Read article →Gulf TimesCXC harnesses the power of natural biopolymers as a regional decarbonization solution.
Read article →Arabian BusinessLeveraging recent mushroom farming in the UAE to reshape the category.
Read article →BeautyMatter has made its mark — gaining a global following and becoming one of the most influential voices covering beauty. These recent stories validate every vector of the Perfect Storm we operate in.
How biotechnology is rewriting skincare's foundation — and why IP-led innovation matters more than ever.
Read on BeautyMatter ↗
A $600B category fighting for relevance — performance is the new luxury currency.
Read on BeautyMatter ↗
Self-assessment claims vs. third-party testing — the same pattern we exposed in our deep-wrinkle and hydration trials.
Read on BeautyMatter ↗
Microplastics aren't just being questioned — they're being banned. Vector two of the Perfect Storm, in motion.
Read on BeautyMatter ↗
PFAS bans cross from proposal to law. The Perfect Storm keeps gathering — and our chitosan platform is ready.
Read on BeautyMatter ↗